We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
+10.96%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$5.37B
AUM Growth
+$652M
Cap. Flow
+$278M
Cap. Flow %
5.18%
Top 10 Hldgs %
33.04%
Holding
214
New
23
Increased
122
Reduced
48
Closed
21

Top Buys

Rank Stock Value
1
PAYC icon
Paycom
PAYC
+$80.7M
2
GENI icon
Genius Sports
GENI
+$58.9M
3
ZETA icon
Zeta Global
ZETA
+$46.6M
4
MGNI icon
Magnite
MGNI
+$46.1M
5
BBBY
Bed Bath & Beyond
BBBY
+$43.9M

Top Sells

Rank Stock Value
1
KLIC icon
Kulicke & Soffa
KLIC
+$73.6M
2
ETSY icon
Etsy
ETSY
+$60.1M
3
DMYD
dMY Technology Group, Inc. II
DMYD
+$49.7M
4
CLDR
Cloudera, Inc.
CLDR
+$47.8M
5
SPT icon
Sprout Social
SPT
+$36.3M

Sector Composition

Rank Sector Weight
1 Technology 36.73%
2 Healthcare 17.37%
3 Industrials 15.63%
4 Consumer Discretionary 9.57%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLDR
176
DELISTED
Cloudera, Inc.
CLDR
$2.53M 0.05%
159,347
-3,511,121
-96% -$47.8M
JNCE
177
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$2.43M 0.05%
357,817
+18,848
+6% +$157K
AUTL
178
Autolus Therapeutics
AUTL
$567M
$2.4M 0.04%
360,955
+20,008
+6% +$124K
TTEK icon
179
Tetra Tech
TTEK
$9B
$2.06M 0.04%
84,375
-99,230
-54% -$2.5M
XERS icon
180
Xeris Biopharma Holdings
XERS
$1.45B
$1.83M 0.03%
450,414
+16,704
+4% +$63.7K
NGNE icon
181
Neurogene
NGNE
$706M
$1.8M 0.03%
9,754
-272
-3% -$60.2K
XENE icon
182
Xenon Pharmaceuticals
XENE
$6.14B
$1.55M 0.03%
83,249
+161
+0.2% +$2.97K
VERI icon
183
Veritone
VERI
$131M
$1.43M 0.03%
+72,579
New +$1.58M
HDSN
184
Hudson Technologies
HDSN
$240M
$1.39M 0.03%
409,423
-288,748
-41% -$696K
PCRX icon
185
Pacira BioSciences
PCRX
$971M
$1.36M 0.03%
22,490
+7,012
+45% +$444K
KRRO icon
186
Korro Bio
KRRO
$200M
$1.27M 0.02%
2,550
+504
+25% +$246K
SWIR
187
DELISTED
Sierra Wireless
SWIR
$826K 0.02%
+43,483
New +$677K
RGEN icon
188
Repligen
RGEN
$9.21B
$794K 0.01%
3,976
-32,552
-89% -$6.31M
MPAA icon
189
Motorcar Parts of America
MPAA
$231M
$475K 0.01%
21,184
-7,157
-25% -$163K
XENT
190
DELISTED
Intersect ENT, Inc
XENT
$445K 0.01%
26,034
+12,207
+88% +$229K
ENPC.WS
191
DELISTED
Executive Network Partnering Corporation Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
ENPC.WS
$429K 0.01%
432,969
+165,906
+62% +$155K
DMTK
192
DELISTED
DermTech, Inc. Common Stock
DMTK
$382K 0.01%
+9,183
New +$377K
RCEL icon
193
Avita Medical
RCEL
$239M
$263K ﹤0.01%
+12,815
New +$253K
BL icon
194
BlackLine
BL
$1.72B
– –
-15,936
Closed -$1.73M
BLDP
195
Ballard Power Systems
BLDP
$766M
– –
-214,937
Closed -$5.23M
CDTX
196
DELISTED
Cidara Therapeutics
CDTX
– –
-2,504
Closed -$133K
ECPG icon
197
Encore Capital Group
ECPG
$2.06B
– –
-24,880
Closed -$1M
FENC icon
198
Fennec Pharmaceuticals
FENC
$383M
– –
-217,295
Closed -$1.35M
GAN
199
DELISTED
GAN Ltd
GAN
– –
-130,593
Closed -$2.38M
HUBS icon
200
HubSpot
HUBS
$10.7B
– –
-4,848
Closed -$2.2M
5 6 7
8
9

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return

Granahan Investment Management's Q2 2021 Portfolio in Review

As of Q2 2021, Granahan Investment Management held 214 positions worth $5.37B, up 14% from $4.72B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Granahan Investment Management deployed $278M of net new capital in Q2 2021, opening 23 new positions and adding to 122 existing holdings. Its largest new stake was Genius Sports: 2,972,846 shares worth $55.8M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Kulicke & Soffa, an estimated $73.6M trimmed.

  • Granahan Investment Management's largest Q2 2021 buy was Genius Sports: 2,972,846 shares worth $55.8M.
  • Granahan Investment Management added most to Paycom in Q2 2021, an estimated $80.7M increase.
  • Granahan Investment Management's biggest Q2 2021 reduction was Kulicke & Soffa, cutting an estimated $73.6M.
  • Granahan Investment Management fully exited dMY Technology Group, Inc. II in Q2 2021, selling an estimated $49.7M.
  • Granahan Investment Management's ten largest holdings make up 33% of its $5.37B portfolio in Q2 2021.
  • Granahan Investment Management opened 23 new positions and closed 21 in Q2 2021.
  • Granahan Investment Management's portfolio value rose 14% quarter-over-quarter to $5.37B.

Based on Granahan Investment Management's 13F filing for Q2 2021, filed 16 Aug 2021.